This pharmacological support can be a game-changer, allowing for more manageable and sustainable weight management practices
Last year, the drugmaker submitted an application for approving tirzepatide for the treatment of HFpEF and obesity to the European Medicines Agency (EMA) and plans to submit it to other regulatory agencies soon
Acute pancreatitis and type 2 diabetes mellitus: glp-1 receptor agonist or idiopathic, a diagnostic dilemma, a case report with literature review
"I started getting injection site reactions - swelling and itching with splotches that have yet to fade, even after a month." - u/Grouchy-Gur-2911 The inconsistency why some people react from the start, while others only after weeks or dose changes is a recurring theme
Members describe the same pattern
Thyroid C-cell tumors: Ozempic carries a boxed warning due to the potential risk of thyroid C-cell tumors based on findings in rodents